New Course on CDISC Standards

New Course on CDISC Standards

Clinical information tends to be more complex, comes from multiple sources in different formats. As a result, clinical data submission has become time-consuming, costly and error-prone. CDISC® (Clinical Data Interchange Standards Consortium) established new data standards to speed up data-review and improve clinical data [...]

Read More

New Infographic: Why choose open-source EDC?

New Infographic: Why choose open-source EDC?

  This infographic is a visual and appealing way to understand why open-source Electronic Data Capture (EDC) is an alternative of choice to proprietary systems or paper-based studies. Do you own a website, a forum or a blog on clinical [...]

Read More
No Thumbnail

BioNews – 05/16/2013

TOP NEWS Headline Company Type Amgen, Novartis aim to fuel biotech startups in alliances with Atlas Venture                 St. Jude [...]

May 16, 2013     No Comments
Read More
No Thumbnail

BioNews – 05/15/2013

TOP NEWS Headline Company Type Roche gains FDA sign-off on lung cancer companion Dx   GlaxoSmithKline gains blockbuster FDA approval [...]

May 15, 2013     No Comments
Read More
New Course on CDISC Standards

New Course on CDISC Standards

Clinical information tends to be more complex, comes from multiple sources in different formats. As a result, clinical data submission has [...]

May 7, 2013     No Comments
Read More
New Infographic: Why choose open-source EDC?

New Infographic: Why choose open-source EDC?

  This infographic is a visual and appealing way to understand why open-source Electronic Data Capture (EDC) is an alternative [...]

May 3, 2013     No Comments
Read More
Challenges and benefits of EDC adoption

Challenges and benefits of EDC adoption

Clinical research is one of the most expensive areas of drug development. Bringing an approved new drug from initial private [...]

Apr 26, 2013     No Comments
Read More
BioNews | April 15th,2013 | Roche and Portola

BioNews | April 15th,2013 | Roche and Portola

TOP NEWS Headline Company Type Roche, billionaire-backed biotech partner on hep C drug in China Roche & Ascletis Collaboration FUNDING [...]

Apr 15, 2013     No Comments
Read More